GLP-1 Medications for Weight Loss: How They Work, Results, and Skin Effects

You have heard the names everywhere, watched friends drop weight, and wondered whether GLP-1 medications could actually work for you, or whether the headlines are overblown. It is a fair question, and you deserve a clear, honest answer before you decide anything.
Here is the short version: GLP-1 medications are a class of injectable drugs that help many people lose a meaningful amount of weight by curbing appetite and slowing digestion. They are not magic, they are not for everyone, and they come with real trade-offs, including some you might notice in your skin. This guide walks through how they work, what results the research shows, and what to watch for.
What are GLP-1 medications, and how do they work?
GLP-1 medications mimic a natural hormone called glucagon-like peptide-1, which your gut releases after you eat. According to the Mayo Clinic, these drugs work in two main ways: they act on the brain to reduce appetite and increase the feeling of fullness, and they slow how quickly your stomach empties. The result is that you feel satisfied sooner, stay full longer, and naturally take in fewer calories.
Several of these medications exist. Semaglutide and tirzepatide are the most effective for weight loss, while older options like liraglutide and dulaglutide are also effective. Some were first developed to treat type 2 diabetes and later approved or studied for weight management. They are given as injections, usually once a week, though dosing and approval vary by specific drug.
How much weight can you lose on a GLP-1?
This is the question most people really want answered, and the clinical trial data is genuinely strong. In the STEP 1 trial of 1,961 adults, once-weekly semaglutide 2.4 mg produced a mean body-weight loss of 14.9% compared with 2.4% on placebo. In the STEP 3 trial of 611 adults over 68 weeks, semaglutide combined with intensive behavioral therapy reduced body weight by 16.0% versus 5.7% with placebo.
A meta-analysis of 16 randomized controlled trials, including 7,024 participants, found that 79.90% of patients treated with semaglutide lost weight, compared with 30.30% on placebo. In head-to-head categorical comparisons, tirzepatide consistently outperformed semaglutide across weight-loss thresholds ranging from 5% to 20%. Results vary from person to person, and these numbers reflect medication used alongside diet and lifestyle changes, not in place of them.
Do the results last?
Durability matters, because no one wants to lose weight only to regain it. The 2-year STEP 5 trial offers reassurance here: semaglutide 2.4 mg reduced body weight by 15.2% at week 104, compared with 2.6% with placebo, a treatment difference of 12.6 percentage points. In plain terms, people who stayed on the medication held onto most of their loss over two years.
The important caveat is that GLP-1 medications generally work while you take them. They manage appetite and metabolism actively, so stopping abruptly can lead to regaining weight. This is a long-term treatment decision, and it is worth discussing maintenance plans with your clinician before you start.
How do GLP-1 medications affect your skin?
Rapid weight loss changes more than the number on the scale, and your skin often shows it. The American Academy of Dermatology notes that losing fat quickly can lead to facial changes sometimes nicknamed Ozempic face, along with skin laxity, sagging, and hair shedding. These are largely a consequence of fast fat loss rather than a direct toxic effect of the drug.
Beyond the cosmetic changes, peer-reviewed reviews describe a mixed dermatologic picture. On the helpful side, the reduced systemic inflammation that comes with these medications may benefit inflammatory skin conditions such as hidradenitis suppurativa and psoriasis. On the cautionary side, reported adverse effects include injection-site reactions, itching, hives, and, rarely, a blistering condition called bullous pemphigoid.
- Facial volume loss and sagging (Ozempic face) from rapid fat reduction
- Skin laxity and looser skin as weight drops quickly
- Increased hair shedding in some people
- Injection-site reactions, itching, or hives
- Possible benefit for hidradenitis suppurativa and psoriasis from reduced inflammation
- Rare blistering reactions such as bullous pemphigoid
Who are GLP-1 medications for?
These medications are typically prescribed for people with obesity or overweight, often alongside other health conditions. They are part of a broader picture: per CDC NHANES data from August 2021 to August 2023, U.S. adult obesity prevalence was 40.3%, and severe obesity prevalence was 9.4%. By 2024, every U.S. state had at least 25% adult obesity. For many people, these drugs are a tool to address a genuine medical condition, not a shortcut for vanity.
Whether a GLP-1 is right for you depends on your medical history, current medications, and personal goals. They are prescription medications that require clinician oversight, both to determine if you are a candidate and to manage dosing and side effects safely over time.
When should you see a doctor?
Always start by talking with a qualified clinician before beginning any GLP-1 medication. They can review your history, screen for conditions that make these drugs unsafe, and set up appropriate monitoring. Never source these medications without a prescription or adjust your own dose.
Seek prompt medical care if you develop severe or persistent vomiting, intense abdominal pain, signs of an allergic reaction such as facial swelling or trouble breathing, or a new blistering skin rash. Facial swelling and difficulty breathing can be an emergency. For skin and hair concerns that bother you during weight loss, a dermatologist can suggest practical management strategies.
Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before starting any new skincare treatment, especially if you have underlying health conditions, are pregnant, or are taking medications.






